Enhanced oral care reduced hospital-acquired pneumonia in randomized trial
“Providing oral care in hospitals is often deprioritized in busy environments."
By
Meg Barbor
August 17, 2026
Clinical Scorecard: Enhanced oral care reduced hospital-acquired pneumonia in randomized trial
At a Glance
Category Detail
Condition Non-ventilator hospital-acquired pneumonia (NV-HAP)
Key Mechanisms Enhanced oral care reduces oral bacterial burden, potentially lowering aspiration-related pneumonia risk.
Target Population Adults aged 18 years or older admitted to medical or stroke wards.
Care Setting Hospital wards
Key Highlights
The HAPPEN trial demonstrated a 60% lower hazard of NV-HAP with enhanced oral care. The intervention included oral-care products, education, and audit feedback. No adverse events were reported during the trial. The study involved 8,870 patients with a mean age of 72.5 years. Oral care compliance increased significantly from 15.8% to 61.9% post-intervention.
Guideline-Based Recommendations
Diagnosis
NV-HAP diagnosis based on European Centre for Disease Prevention and Control criteria.
Management
Implement enhanced oral care programs in hospital settings to reduce NV-HAP.
Monitoring & Follow-up
Monitor compliance with oral care protocols and NV-HAP incidence.
Risks
Consider potential challenges in implementing dedicated oral care support in busy hospital environments.
Patient & Prescribing Data
Adults admitted to hospital wards for at least 48 hours.
Oral care should be prioritized as a preventive strategy for NV-HAP.
Clinical Best Practices
Provide oral-care products and education to patients and staff. Utilize audit and feedback mechanisms to enhance oral care compliance. Ensure dedicated support for oral care activities in hospital settings.
Related Resources & Content